Dr. Kiran C. Patel College of Allopathic Medicine (NSU MD) 2023–2024 70 6. Group A streptococcal disease (i.e., strep throat) until 24 hours after treatment has been initiated 7. draining infectious skin lesions (e.g., MRSA, HSV) that are unable to be covered appropriately 8. viral gastroenteritis including norovirus and rotavirus 9. viral conjunctivitis, (i.e., pink eye) until on appropriate treatment for >24 hours A student who has a communicable disease and is unsure whether the student should participate in patient care should seek medical care by a private physician or a physician on staff at the NSU Student Medical Center. All students with a communicable disease must receive written medical clearance by a physician prior to returning to clinical care activities. A case-by-case evaluation of each infected student will be done by each student’s physician to determine eligibility to perform the duties required on the clinical rotation. Based on the recommendations of the physician, it is the responsibility of each infected medical student to notify the NSU MD Office of Student Affairs if the student is unable to perform clinical work. Appropriate documentation is required. All such notifications will be kept strictly confidential. Prior to the start of clinical experiences, a student who has chronic hepatitis B virus (HBV), chronic hepatitis C virus (HCV), or HIV/AIDS is required to notify the Office of Student Affairs of the student’s status. All such notifications will be kept strictly confidential. Prior to the start of any clinical experiences, infected students are required to seek medical consultation with a physician to determine their ability to perform the duties required of the clinical rotation. Medical students are not obligated to answer patient questions related to their own HBV/HCV/HIV/AIDS status, nor shall they answer such questions related to other students, other health care personnel, or patients. Serologic testing of medical students for HBV/HCV/HIV antibody will not be performed routinely unless the person is seropositive. Testing is recommended when there has been a documented needle or sharp instrument puncture or mucous membrane exposure to the blood or body fluids of patients, or when there has been a medical studentto-patient exposure. Refer to the Exposure at NSU, Exposure at an NSU MD Affiliate Site Not Located on the Campus of NSU, and other policies and procedures in this handbook. Students who are at high risk of infection from patients or other personnel because of their immune status or any other reason are encouraged to discuss their work responsibilities and educational activities with their personal health care provider. If the health care provider believes there are certain assignments the individual should not accept for personal health reasons, this should be discussed with the ADASA or designee. Accommodations may be available under the Technical Standards. Students should contact NSU’s Student Disability Services to see whether such accommodations are available. Medical students with HBV/HCV/HIV seropositivity shall have periodic physical examinations by their private physician or a physician on staff at the NSU Student Medical Center. Written health clearance will be provided to the ADASA or designee, who will notify the student’s clerkship director of the student’s ability to return to practice direct patient care. All correspondence will be kept confidential and will not be used as a basis for discrimination. The greatest theoretical risk of medical student-to-patient transmission of HBV, HCV or HIV/AIDS involves invasive or exposure-prone procedures with manipulation of needles or other sharp objects not under direct visualization. Medical students who have HBV/HCV/HIV seropositivity may not perform invasive or exposure-prone procedures unless such activity is approved in writing by 1) an expert panel duly constituted to guide and review performance of such procedures (see Centers for Disease Control and Prevention [CDC] guidelines for definition of exposure-prone procedures and recommendations for expert panel oversight), 2) the student’s personal physician (who may be a physician from the NSU Student Medical Center), 3) the clinical clerkship director, and 4) the ADASA or designee.
RkJQdWJsaXNoZXIy NDE4MDg=